Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decision Making: Traditional Method01:14

Decision Making: Traditional Method

5.7K
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
5.7K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

692
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
692
Null and Alternative Hypotheses01:16

Null and Alternative Hypotheses

13.3K
The actual hypothesis testing begins by considering two hypotheses. They are termed  the null hypothesis and the alternative hypothesis. These hypotheses contain opposing viewpoints.
The null hypothesis, denoted by H0 is a statement of no difference between the variables—they are not related. This can often be considered the status quo. As  a result if you cannot accept the null, it requires some action.
The alternative hypothesis, denoted by H1 or Ha, is a claim about the...
13.3K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

692
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
692
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

475
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
475
Censoring Survival Data01:09

Censoring Survival Data

628
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
628

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and immunotherapy of patients with pancreatic cancer.

Frontiers in endocrinology·2023
Same author

Numerical investigation of localization in two-dimensional quasiperiodic mosaic lattice.

Journal of physics. Condensed matter : an Institute of Physics journal·2023
Same author

Determination Methods of the Risk Factors in Food Based on Nanozymes: A Review.

Biosensors·2023
Same author

Mid-infrared single photon detector with superconductor Mo<sub>0.8</sub>Si<sub>0.2</sub> nanowire.

Science bulletin·2023
Same author

Succulent-plant-like Ni-Co alloy efficient catalysts for direct borohydride fuel cells.

Dalton transactions (Cambridge, England : 2003)·2023
Same author

Age-level bias correction in brain age prediction.

NeuroImage. Clinical·2023
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 17, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.4K

An alternative empirical likelihood method in missing response problems and causal inference.

Kaili Ren1, Christopher A Drummond2, Pamela S Brewster2

  • 1Department of Mathematics and Statistics, The University of Toledo, Toledo, 43606, OH, U.S.A.. Kaili.Ren@rockets.utoledo.edu.

Statistics in Medicine
|July 16, 2016
PubMed
Summary
This summary is machine-generated.

Missing data in studies can cause bias. This research introduces a new doubly robust estimator that improves efficiency and performance, particularly when propensity scores are correctly modeled, offering a valuable tool for causal inference.

Keywords:
average treatment effectcausal inferenceempirical likelihoodmissing at randomobservational studypropensity score

More Related Videos

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.3K

Related Experiment Videos

Last Updated: Mar 17, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.4K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.3K

Area of Science:

  • Statistics
  • Biostatistics
  • Econometrics

Background:

  • Missing data is a pervasive issue in medical, social, and economic research.
  • Complete case analysis can introduce bias when data is missing at random.
  • Existing methods like inverse probability weighting and augmented inverse probability weighting have limitations.

Purpose of the Study:

  • To introduce a novel empirical likelihood-based estimator for handling missing data.
  • To evaluate the performance of the proposed estimator against existing methods.
  • To demonstrate the application of the estimator in causal inference and real-world studies.

Main Methods:

  • Developed a doubly robust and locally efficient empirical likelihood-based estimator.
  • Utilized simulation studies to compare the proposed estimator with existing methods.
  • Applied the method to an observational study on smoking within the Cardiovascular Outcomes in Renal Atherosclerotic Lesions trial.

Main Results:

  • The proposed empirical likelihood estimator demonstrates improved performance when the propensity score model is correctly specified.
  • The estimator possesses double-robustness properties, ensuring valid inference under certain model misspecifications.
  • The method is effective for estimating average treatment effects in observational causal inference.

Conclusions:

  • The novel empirical likelihood estimator offers a robust and efficient alternative for addressing missing data in statistical studies.
  • The method shows particular promise when propensity score modeling is accurate.
  • This approach has practical implications for analyzing observational data, including clinical trials.